KARO PHARMA AB (PUBL

KARO
Delayed Nasdaq Stockholm - 11:29 2022-11-24 am EST
60.70 SEK +0.33%

Turn to zoom
Prev.60.70000000
Open60.40000000
High61.00000000
Low60.40000000
Volume52 254
Latest news
11/22
11/11
11/10
11/10
Chart KARO PHARMA AB (PUBL)
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance60,865,762,9
Spread/Res.-0,13%-7,6%-3,5%
Spread/Supp.0,25%9,8%10%
Support60,655,355,0
Financials
Sales 2021 2 961 M 279 M 279 M
Net income 2021 -17,5 M -1,64 M -1,64 M
Net Debt 2021 5 471 M 515 M 515 M
P/E ratio 2021 -750x
Yield 2021 -
Capitalization 16 587 M 1 561 M 1 561 M
EV / Sales 2020 5,88x
EV / Sales 2021 6,41x
Nbr of Employees 225
Free-Float 1,74%
Company
Karo Pharma AB, formerly known as Karo Bio AB, is a Sweden-based biopharmaceutical company engaged in the research and development of drugs based on the nuclear receptors. The Company’s pipeline comprises three projects: Estrogen Receptor Beta (ERbeta) cancer, a platform, which focuses on the...
Sector :
Other Pharmaceuticals
Calendar :
2023-02-16 Earnings Release

Income Statement Evolution